Sweden healthcare costs rise due to advanced medical treatments

A report by the Swedish Association of Local Authorities and Regions (SKR) indicates that healthcare costs between 2014 and 2024 increased by 10 percent more than can be explained by inflation, wages, or demographic changes. This surplus amounts to nearly 37 billion SEK in today’s value.

Analyst Douglas Knutsson explains that the rise is driven by more advanced diagnostics, treatments, and pharmaceuticals. The most significant cost increases are seen in cancer care, where medical technology advancements allow older and more fragile patients to receive intensive treatment. Conversely, cardiovascular disease costs have not risen as sharply, partly due to improved preventive care and follow-up in primary care. Despite the improved medical outcomes, the report emphasizes the ongoing challenge of securing necessary funding and the need for continuous prioritization of medical interventions.